EXAPRIN-AC
- Manufacturer
- HART Health
- Effective date
- 2024-12-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 00:40:25
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each caplet)
Aspirin (NSAID*) 500 mg *nonsteroidal anti-inflammatory drug
Caffeine 32.5 mg
OTC - PURPOSE SECTION
Purpose
Pain reliever/fever reducer
Pain reliever aid
INDICATIONS & USAGE SECTION
Uses
for the temporary relief of minor aches and pains due to
■ headache
■ muscular aches
■ backache pain
■ minor arthritis pain
■ common cold
■ toothache
■ menstrual cramps
Temporarily reduces fever
WARNINGS SECTION
Warnings
Reye's syndrome:
Children and teenagers should not use this medicine for chicken pox or flu symptoms before a doctor is consulted about Reye's Syndrome, a rare but serious illness reported to be associated with salicylates.
Allergy alert:
Magnesium salicylate may cause a severe allergic reaction which may include:
■ hives
■ facial swelling
■ asthma (wheezing)
■ shock
Stomach bleeding warning:
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
■ are age 60 or older
■ have had stomach ulcers or bleeding problems
■ take a blood thinning (anticoagulant) or steroid drug
■ take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
■ have 3 or more alcoholic drinks every day while using this product
■ take more or for a longer time than directed
OTC - DO NOT USE SECTION
Do not use if you have ever had an allergic reaction to any pain reliever/fever reducer.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if
■ stomach bleeding warning applies to you
■ you have a history of stomach problems, such as heartburn
■ you have asthma, high blood pressure, heart disease, liver cirrhosis, or kidney disease
■ you are taking a diuretic
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you take any drug for diabetes, gout or arthritis
OTC - STOP USE SECTION
Stop use and ask a doctor if
■ an allergic reaction occurs, seek medical help right away
■ fever worsens or lasts more than 3 days
■ pain worsens or lasts more than 10 days
■ you have any of the following signs of stomach bleeding: feel faint, vomit blood, have bloody or black stools, or stomach pain that does not get better
■ ringing in the ears or loss of hearing occurs
■ new symptoms occur
■ redness or swelling is present
These could be signs of a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use aspirin at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222
DOSAGE & ADMINISTRATION SECTION
Directions
Do not take more than directed.
Adults and children 12 years of age and over:
■ take 2 caplets with a full glass of water every 6 hours while symptoms persist
■ do not take more than 8 caplets in 24 hours unless directed by a doctor
Children under 12 years: ask a doctor
OTHER SAFETY INFORMATION
Other information
■ caplets enclosed in a sealed packet
■ do not use if packet is torn, cut or open
■ store at 59° to 86°F (15°-30°C)
■ avoid excessive heat and humidity
INACTIVE INGREDIENT SECTION
Inactive ingredients
corn starch, hypromellose, maltodextrin, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 702316 | aspirin 500 MG / caffeine 32.5 MG Oral Tablet | PSN | 3 |
| 2723574 | Exaprin Extra Strength 500 MG / 32.5 MG Oral Tablet | PSN | 3 |
| 2723574 | aspirin 500 MG / caffeine 32.5 MG Oral Tablet [Exaprin Extra Strength] | SBD | 3 |
| 702316 | aspirin 500 MG / caffeine 32.5 MG Oral Tablet | SCD | 3 |
| 702316 | ASA 500 MG / Caffeine 32.5 MG Oral Tablet | SY | 3 |
| 2723574 | ASA 500 MG / caffeine 32.5 MG Oral Tablet [Exaprin Extra Strength] | SY | 3 |
| 2723574 | Exaprin Extra Strength (aspirin 500 MG / caffeine 32.5 MG) Oral Tablet | SY | 3 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASPIRIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| CAFFEINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50332-0143 | EXAPRIN-AC (ASPIRIN,CAFFEINE) TABLET, FILM COATED [HART HEALTH] | 3 | Unmatched | 20241206_cc128ced-dc95-47f8-9e16-87680ce91b18.zip |
Products#
Every source-derived product name is available through these pages.
- EXAPRIN-AC
- Aspirin,Caffeine
- ASPIRIN
- STARCH, CORN
- HYPROMELLOSE, UNSPECIFIED
- MALTODEXTRIN
- POLYETHYLENE GLYCOL, UNSPECIFIED
- CAFFEINE
- MICROCRYSTALLINE CELLULOSE
- SODIUM LAURYL SULFATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50332-0143 | 50332-0143-3, 50332-0143-4, 50332-0143-7, 50332-0143-8 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASPIRIN | R16CO5Y76E | ACTIB |
| STARCH, CORN | O8232NY3SJ | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| CAFFEINE | 3G6A5W338E | ACTIB |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2a948b68-116a-471b-8902-b9ab9455a6b1 | cc128ced-dc95-47f8-9e16-87680ce91b18 | 2024-12-04 | Warnings | 2a948b68-116a-471b-8902-b9ab9455a6b1 cc128ced-dc95-47f8-9e16-87680ce91b18 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
